← FDA DRUG APPROVALS

FDA ANDA · ANDA090439

VANCOMYCIN HYDROCHLORIDE

Sponsor: LUPIN

APPLICATION
ANDA090439
TYPE
ANDA
ORIGINAL APPROVAL
2015-01-28
LATEST ACTION
2023-11-03
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

VANCOMYCIN HYDROCHLORIDEDiscontinued
VANCOMYCIN HYDROCHLORIDE EQ 125MG BASE · CAPSULE · ORAL
VANCOMYCIN HYDROCHLORIDEDiscontinued
VANCOMYCIN HYDROCHLORIDE EQ 250MG BASE · CAPSULE · ORAL

Approval history

2023-11-03Labeling · Supplement 6 · standardAP
2023-11-03Labeling · Supplement 4 · standardAP
2023-11-03Labeling · Supplement 2 · standardAP
2023-11-03Labeling · Supplement 5 · standardAP
2023-11-03Labeling · Supplement 1 · standardAP
2015-01-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →